4.8 Article

Biliverdin reductase:: A major physiologic cytoprotectant

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.252626999

Keywords

-

Funding

  1. NIDA NIH HHS [DA-00266, F30 DA005900, K05 DA000074, DA-00074, DA05900, P50 DA000266] Funding Source: Medline

Ask authors/readers for more resources

Bilirubin, an abundant pigment that causes jaundice, has long lacked any clear physiologic role. It arises from enzymatic reduction by biliverclin reductase of biliverdin, a product of heme oxygenase activity. Bilirubin is a potent antioxidant that we show can protect cells from a 10,000-fold excess of H2O2. We report that bilirubin is a major physiologic antioxiclant cytoprotectant. Thus, cellular depletion of bilirubin by RNA interference markedly augments tissue levels of reactive oxygen species and causes apoptotic cell death. Depletion of glutathione, generally regarded as a physiologic antioxiclant cytoprotectant, elicits lesser increases in reactive oxygen species and cell death. The potent physiologic antioxiclant actions of bilirubin reflect an amplification cycle whereby bilirubin, acting as an antioxiclant, is itself oxidized to biliverclin and then recycled by biliverdin reductase back to bilirubin. This redox cycle may constitute the principal physiologic function of bilirubin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available